Developing innovative and efficient technology to insert genetic material into cells
Trince has raised €4.0M across 1 funding round from 3 investors, most recently a round in Dec 2021. Based in Ghent, Belgium; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-06 | Other | €4.0M |
| Novalis Biotech Acceleration,Private Investors,Qbic II |
| View deal → |
